Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medical Device Advertising To Be Regulated

This article was originally published in PharmAsia News

Executive Summary

China's State FDA is soliciting public comments on a recently prepared draft of medical device advertising censorship. Companies found advertising misleading information and fraudulent claims of products will have to publish corrections in the same media, and face sales suspension. All future advertisements of medical devices that include the product name, application, performance, structure, mechanism and other features, will need to be examined by provincial monitoring departments before given an approval number. Transgressors will not be allowed to apply to the censorship board for advertisements for up to one year. The deadline for feedback is Jan. 25, 2008. (Click here for more)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066611

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel